89 research outputs found
Tunable Signal-Off and Signal-On Electrochemical Cisplatin Sensor
We report the first electrochemical
cisplatin sensor fabricated
with a thiolated and methylene blue (MB)-modified oligo-adenine (A)-guanine
(G) DNA probe. Depending on the probe coverage, the sensor can behave
as a signal-off or signal-on sensor. For the high-coverage sensor,
formation of intrastrand PtĀ(II)-AG adducts rigidifies the oligo-AG
probe, resulting in a concentration-dependent decrease in the MB signal.
For the low-coverage sensor, the increase in probe-to-probe spacing
enables binding of cisplatin via the intrastrand GNG motif (N = A),
generating a bend in the probe which results in an increase in the
MB current. Although both high-coverage signal-off and low-coverage
signal-on sensors are capable of detecting cisplatin, the signal-on
sensing mechanism is better suited for real time analysis of cisplatin.
The low-coverage sensor has a lower limit of detection, wider optimal
AC frequency range, and faster response time. It has high specificity
for cisplatin and potentially other PtĀ(II) drugs and does not cross-react
with satraplatin, a PtĀ(IV) prodrug. It is also selective enough to
be employed directly in 50% saliva and 50% urine. This detection strategy
may offer a new approach for sensitive and real time analysis of cisplatin
in clinical samples
Electrochemical Detection of Platinum(IV) Prodrug Satraplatin in Serum
We
report the design and fabrication of a reagentless and reusable
electrochemical sensor for detection of satraplatin (SAT), a platinumĀ(IV)
prodrug. The detection strategy is based on the electrocatalytic reaction
between the PtĀ(IV) center of SAT and surface-immobilized methylene
blue. We systematically evaluated the effect of passivating diluent
chain length on the overall sensor performance. Our results show that
the use of a shorter diluent like 2-mercaptoethanol is more advantageous
than using a longer and more passivating diluent such as 6-mercapto-1-hexanol.
Independent of the use of cyclic voltammetry or chronoamperometry
as the sensor interrogation technique, all three sensors, each passivated
with a different alkanethiol diluent, have been demonstrated to be
sensitive; the limit of detection is in the range of 1ā10 Ī¼M.
They are also highly specific and do not respond to PtĀ(II) drugs
such as cisplatin and carboplatin. More importantly, they are selective
enough to be employed directly in 50% serum. This sensing strategy
has potential applications in clinical pharmacokinetics studies
Electrochemical Gold(III) Sensor with High Sensitivity and Tunable Dynamic Range
We
report the design and fabrication of a sensitive, specific,
and selective electrochemical ion (E-ION) sensor for detection of
AuĀ(III). The signaling mechanism is based on the interactions between
AuĀ(III) and adenine; formation of these complexes rigidifies the methylene
blue (MB)-modified oligoadenine probes, resulting in a concentration-dependent
reduction in the MB signal. The dynamic range of the sensor can be
tuned by simply changing the length of the DNA probe (six (A6) or
12 (A12) adenines). Independent of the probe length, both sensors
have demonstrated to be sensitive, with a limits of detection of 50
and 20 nM for the A6 and A12 sensors, respectively. With further optimization,
this sensing strategy may offer a promising approach for analyzing
AuĀ(III)
Cross-tabulation by bike-sharing usage and level of satisfaction.
<p>Cross-tabulation by bike-sharing usage and level of satisfaction.</p
Proportional distribution of usage and satisfaction degree of bike-sharing.
<p>Proportional distribution of usage and satisfaction degree of bike-sharing.</p
Bike-sharing system (bicycles and docking stations) deployment in Ningbo.
<p>Bike-sharing system (bicycles and docking stations) deployment in Ningbo.</p
The rapid growth of bike-sharing programmes.
<p>The rapid growth of bike-sharing programmes.</p
Average daily use of bike-sharing across all months.
<p>Average daily use of bike-sharing across all months.</p
- ā¦